|
WO2009114083A2
|
|
Determinants of antiviral response
|
|
WO2009085256A1
|
|
Anti-hiv compounds
|
|
WO2009042166A1
|
|
Liquid bevirimat dosage forms for oral administration
|
|
WO2008134036A1
|
|
ALPHA-SUBSTITUTED ARYLMETHYL PIPERAZINE PYRAZOLO[1,5-α]PYRIMIDINE AMIDE DERIVATIVES
|
|
WO2008091532A1
|
|
Salts of 3-o-(3',3'-dimethylsuccinyl)betulinic acid and solid state forms thereof
|
|
WO2008057420A2
|
|
Extended triterpene derivatives
|
|
US2008039428A1
|
|
Antiretroviral combination therapy
|
|
ZA200805703B
|
|
Preparation of pharmaceutical salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid
|
|
MX2007011981A
|
|
Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine.
|
|
ZA200704806B
|
|
Novel betulin derivatives, preparation thereof and use thereof
|
|
TW200628161A
|
|
Novel betulin derivatives, preparation thereof and use thereof
|
|
MXPA06013698A
|
|
Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein.
|
|
ZA200610825B
|
|
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
|
|
AU2005224260A1
|
|
Pharmaceuticals salts of 3-O-(3',3'-dimethylsuccinyl) betulinic acid
|
|
ZA200608624B
|
|
Pharmaceutical salts of 3-0(3',3'-dimethylsuccinyl) betulinic acid
|
|
AU2004276307A1
|
|
Novel triterpene derivatives, preparation thereof and use thereof
|
|
ZA200602758B
|
|
Novel triterpene derivatives, preparation thereof and use thereof
|
|
US2005020548A1
|
|
Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
|
|
US7537765B2
|
|
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
|
|
CA2514563A1
|
|
Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
|
